Lavoisier S.A.S.
14 rue de Provigny
94236 Cachan cedex
FRANCE

Heures d'ouverture 08h30-12h30/13h30-17h30
Tél.: +33 (0)1 47 40 67 00
Fax: +33 (0)1 47 40 67 02


Url canonique : www.lavoisier.fr/livre/medecine/esophageal-cancer/descriptif_4963787
Url courte ou permalien : www.lavoisier.fr/livre/notice.asp?ouvrage=4963787

Esophageal Cancer (2nd Ed., 2nd ed. 2023) Diagnosis and Treatment

Langue : Anglais

Coordonnateurs : Schlottmann Francisco, Ferri Lorenzo, Molena Daniela, Patti Marco G.

Couverture de l’ouvrage Esophageal Cancer

This book provides comprehensive and practical guidance for the management of esophageal cancer. It presents a detailed review of the pathophysiology, clinical staging, treatment, and outcomes of patients with esophageal cancer. Chapters cover the epidemiology of the disease, latest diagnostic and staging tools, systemic therapies, and the current open and minimally invasive surgical techniques including transhiatal, Ivor Lewis and McKeown esophagectomy. 

Esophageal Cancer: Diagnosis and Treatment compiles experience gained across a variety of medical disciplines, with contributions from world renowned surgeons, gastroenterologists, and medical oncologists.  Thanks to its multidisciplinary authorship, this book represents a unique resource for anybody who takes care of patients with esophageal cancer.

Esophageal anatomy.- Esophageal Squamous Cell Cancer: Pathogenesis and epidemiology.- Esophageal Adenocarcinoma: Pathogenesis and epidemiology.- Endoscopy and Endoscopic Ultrasound in esophageal cancer.- Radiologic evaluation of esophageal cancer.- Staging of esophageal cancer: implications for therapy.- Endoscopic resection of superficial esophageal cancer.- Neoadjuvant and adjuvant therapy - Restaging after neoadjuvant therapy.- Definitive chemo-radiation in esophageal cancer.- Immunotherapy in Esophageal Cancer.- Anesthesia in esophageal cancer surgery.- Transhiatal esophagectomy.- McKeown esophagectomy.- Hybrid (Laparoscopy – Thoracotomy) Esophagectomy.- Minimally Invasive transhiatal esophagectomy.- Laparoscopic and Thoracoscopic Ivor Lewis Esophagectomy.- Robotic Ivor-Lewis Esophagectomy.- Minimally invasive McKeown esophagectomy.- Esophagectomy with colonic interposition.- Perioperative care and management of post-operative complications.- Quality of life after esophagectomy.- Palliative Treatment of Esophageal Cancer.

Francisco Schlottmann received his medical degree with honors at the University of Buenos Aires in Argentina. He then completed his general surgery residency at the Hospital Alemán of Buenos Aires. After his surgical training, Dr. Schlottmann completed the Soudavar fellowship at Memorial Sloan Kettering Cancer Center, focusing his research on esophageal cancer. He then did a 2-year gastrointestinal surgery fellowship at the University of North Carolina, focusing his clinical and research activities on foregut disorders. Dr. Schlottmann obtained his Master of Public Health at the University of North Carolina Gillings School of Global Public Health. He also completed a 1-year Minimally Invasive and Robotic Surgery Fellowship at the University of Illinois at Chicago. He currently serves as Clinical Instructor at the University of Illinois at Chicago and as Affiliate Professor of Surgery at the Hospital Alemán of Buenos Aires with an active clinical and research interest in esophageal disorders, gastroesophageal reflux disease, obesity, esophageal cancer, and gastric cancer. Dr. Schlottmann is editor of 7 books, has published over 250 journal articles, and has written more than 60 book chapters. 

Lorenzo Ferri is the David S. Mulder Chair in Surgery and a Professor in the Departments of Surgery and Oncology at McGill University in Montreal Canada. He is director of the Division of Thoracic and Upper Gastrointestinal Surgery Surgery and heads the Upper Gastrointestinal Cancer Program at McGill University, one of North America’s largest and most comprehensive. Dr Ferri couples this clinical activity with an active translational and fundamental research program investigating the mechanisms of therapy resistance in gastro-esophageal adenocarcinoma and the inflammatory basis of cancer progression. He is the recipient of numerous peer review grants, including from the Canadian Institutes of Health Research, Canadian Cancer Society, United States D

Provides key learning objectives to emphasize key points and aid content revision Written by a cadre of world-renowned experts in the management of esophageal cancer patients This new revised edition contains detailed guidance on pre-treatment staging and multi-modality treatment options

Date de parution :

Ouvrage de 230 p.

17.8x25.4 cm

Disponible chez l'éditeur (délai d'approvisionnement : 15 jours).

116,04 €

Ajouter au panier